CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)

Trial Profile

CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Calcium acetate (Primary) ; Sevelamer (Primary) ; Atorvastatin
  • Indications Kidney disorders
  • Focus Pharmacodynamics
  • Acronyms CARE-2
  • Sponsors Nabi Biopharmaceuticals
  • Most Recent Events

    • 26 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top